IP Library Granted Patent US 6,955,909
Granted Patent B1
US 6,955,909 · App. 09/258,518 · Granted Oct 18, 2005

Selection marker gene free recombinant strains

Assignee: DSM N.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,955,909
App. No.
09/258,518
Granted
Oct 18, 2005
Kind
B1
Abstract

The present invention discloses a selection marker free system which can be used to introduce genetic modifications to in bacteria, yeasts and fungi. The system can be employed to introduce or delete desired genes or DNA fragments in the genome of the indicated host species without leaving any undesired DNA i.e. the selection marker used for selection of transformants or other DNA used for cloning. In this way strains have been developed containing only desired genes introduced at desired chromosomal sites. Similarly, desired DNA fragments have been deleted or replaced at desired sites.

Claims (10)

1. A recombinant E. coli strain comprising:

a genome, a genetic modification at a single site of the genome, an exogenous Aspergillus acetamidase selection marker gene in the genome,

wherein the exogenous Aspergillus acetamidase selection marker gene and at least one endogenous restriction endonuclease cutting site are deleted from the genome,

wherein said E. coli strain genome is free of any foreign selection marker gene; and

wherein the genetic modification of the genome is selected from the group consisting of integration of an exogenous DNA fragment into the genome and a deletion of an exogenous DNA fragment from the genome.

2. A recombinant Bacillus strain comprising:

a genome, a genetic modification at a single site of the genome, an exogenous Aspergillus acetamidase selection marker gene in the genome,

wherein the exogenous Aspergillus acetamidase selection marker gene and at least one endogenous restriction endonuclease cutting site are deleted from the genome,

wherein said Bacillus strain genome is free of any foreign selection marker gene;

and wherein the genetic modification of the genome is selected from the group consisting of integration of an exogenous DNA fragment into the genome and a deletion from the genome.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2003
From: DSM N.V.
To: DSM IP ASSETS B.V.
Reel/Frame 014634/0415 →
CHANGE OF NAME Recorded Jun 6, 2002
From: DSM ANTI INFECTIVES B.V.
To: DSM N.V.
Reel/Frame 012974/0595 →
Priority Claims (1)
EP 93202195 · Jul 23, 1993 · regional
Continuity (2)
Division 0888055700 · Jun 23, 1997
Continuation 0827998000 · Jul 22, 1994